Cumberland Pharmaceuticals Inc (CPIX) - Financial and Strategic SWOT Analysis Review

May 2021 | 57 pages | ID: C85E350E417EN
GlobalData

Abstracts

Cumberland Pharmaceuticals Inc (CPIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cumberland Pharmaceuticals Inc (Cumberland Pharma), is a specialty pharmaceutical company that acquires, develops, and commercializes branded prescription products. Its primary target markets are hospital acute care, gastroenterology, and cancer supportive care. The company offers branded prescription products under Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Ethyol, Totect, Hepatoren, Boxaban, Vasculan, Portaban, and RediTrex brand names. Cumberland Pharma promotes approved products through its hospital and gastroenterology sales forces in the US. The company is also establishing a network of international partners to commercialize its products in their countries. Cumberland Pharma is headquartered in Nashville, Tennessee, the US.

Cumberland Pharmaceuticals Inc Key Recent Developments

Mar 02,2021: Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2020 Financial Results
Dec 01,2020: MonitorMe selects Cumberland to optimize EHR platform and automate billing workflows
Nov 10,2020: Cumberland Pharmaceuticals reports third quarter 2020 financial results & company update
Aug 11,2020: Cumberland Pharmaceuticals reports second quarter 2020 financial results & company update
May 20,2020: Cumberland Pharmaceuticals reports first quarter 2020 financial results & company update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Cumberland Pharmaceuticals Inc - Key Facts
Cumberland Pharmaceuticals Inc - Key Employees
Cumberland Pharmaceuticals Inc - Key Employee Biographies
Cumberland Pharmaceuticals Inc - Major Products and Services
Cumberland Pharmaceuticals Inc - History
Cumberland Pharmaceuticals Inc - Company Statement
Cumberland Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Cumberland Pharmaceuticals Inc - Business Description
Product Category: Acetadote
Performance
Product Category: Acetadote (acetylcysteine)
Overview
Product Category: Caldolor
Overview
Performance
Product Category: Kristalose
Overview
Performance
Product Category: Omeclamox
Overview
Performance
Product Category: Other
Performance
Product Category: RediTrex
Performance
Product Category: Vaprisol
Overview
Performance
Product Category: Vibativ
Overview
Performance
R&D Overview
Cumberland Pharmaceuticals Inc - Corporate Strategy
Cumberland Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Cumberland Pharmaceuticals Inc - Strengths
Cumberland Pharmaceuticals Inc - Weaknesses
Cumberland Pharmaceuticals Inc - Opportunities
Cumberland Pharmaceuticals Inc - Threats
Cumberland Pharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Cumberland Pharmaceuticals Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 02, 2021: Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2020 Financial Results
Dec 01, 2020: MonitorMe selects Cumberland to optimize EHR platform and automate billing workflows
Nov 10, 2020: Cumberland Pharmaceuticals reports third quarter 2020 financial results & company update
Aug 11, 2020: Cumberland Pharmaceuticals reports second quarter 2020 financial results & company update
May 20, 2020: Cumberland Pharmaceuticals reports first quarter 2020 financial results & company update
May 15, 2020: Cumberland Pharmaceuticals To Announce First Quarter 2020 Financial Results
Apr 28, 2020: Cumberland Pharmaceuticals releases inaugural report on its environmental, social and governance (ESG) activities
Apr 20, 2020: Cumberland Pharmaceuticals receives loan under Paycheck Protection Program
Mar 18, 2020: Cumberland Pharmaceuticals Reports 17% Revenue Growth For The Full Year 2019

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Cumberland Pharmaceuticals Inc, Key Facts
Cumberland Pharmaceuticals Inc, Key Employees
Cumberland Pharmaceuticals Inc, Key Employee Biographies
Cumberland Pharmaceuticals Inc, Major Products and Services
Cumberland Pharmaceuticals Inc, History
Cumberland Pharmaceuticals Inc, Subsidiaries
Cumberland Pharmaceuticals Inc, Key Competitors
Cumberland Pharmaceuticals Inc, Ratios based on current share price
Cumberland Pharmaceuticals Inc, Annual Ratios
Cumberland Pharmaceuticals Inc, Annual Ratios (Cont...1)
Cumberland Pharmaceuticals Inc, Annual Ratios (Cont...2)
Cumberland Pharmaceuticals Inc, Interim Ratios
Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Cumberland Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Cumberland Pharmaceuticals Inc, Performance Chart (2016 - 2020)
Cumberland Pharmaceuticals Inc, Ratio Charts
Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021